KR920700705A - 상처용 겔 조성물 및 이것의 사용방법 - Google Patents

상처용 겔 조성물 및 이것의 사용방법

Info

Publication number
KR920700705A
KR920700705A KR1019910700602A KR910700602A KR920700705A KR 920700705 A KR920700705 A KR 920700705A KR 1019910700602 A KR1019910700602 A KR 1019910700602A KR 910700602 A KR910700602 A KR 910700602A KR 920700705 A KR920700705 A KR 920700705A
Authority
KR
South Korea
Prior art keywords
gel
sodium chloride
wound
gelling agent
chloride concentration
Prior art date
Application number
KR1019910700602A
Other languages
English (en)
Inventor
보가트 래리
알. 번스 레이몬드
엠. 펠리스 마가레트
에이치. 피핀 월레이스
Original Assignee
원본미기재
스코트 페이퍼 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 스코트 페이퍼 캄파니 filed Critical 원본미기재
Publication of KR920700705A publication Critical patent/KR920700705A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Abstract

내용 없음

Description

상처용 겔 조성물 및 이것의 사용방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 약간의 진피 그리고 피하 조직이 파괴되고 가피와 파괴된 부스러기를 함유하는 3단계 상처를 나타낸것이고, 제2도는 제1도의 3단계 상처의 괴사 조직 제거상태를 나타낸 것이고, 제3도는 진피 그리고 표피가 형성되어야 할 2단계 상처를 나타낸 것이고, 제4도는 표피가 형성되어야 할 1단계 상처를 나타낸 것이다.

Claims (22)

  1. 물, 염 그리고 겔화제로 되고, 항복치가 적어도 약 800 포이스이고 겉보기 점도가 약 100,000센티포이스인 겔.
  2. 제1항에 있어서, 겔화제를 4%까지 함유하는 겔.
  3. 제1항에 있어서, 겔화제를 2%까지 함유하는 겔.
  4. 제1항에 있어서, 겔화제가 크산탄 검으로 되는 겔.
  5. 제1항에 있어서, 겔화제가 고분자량 폴리옥시알킬렌 가교 결합된 아크릴산 중합체로 되는 겔.
  6. 제1항에 있어서, 겔화제의 혼합물로 되는 겔.
  7. 제6항에 있어서, 겔화제가 구아르 검 및 로커스트 빈 검인 겔.
  8. 제1항에 있어서, 염화나트륨 농도가 0.9%이하인 겔.
  9. 제1항에 있어서, 염화나트륨 농도가 0.9%인 겔.
  10. 제1항에 있어서, 염화나트륨 농도가 0.9%이상인 겔.
  11. 제10항에 있어서, 염화나트륨 농도가 16내지 30%인 겔.
  12. 제10항에 있어서, 염화나트륨 농도가 30% 초과하고 그리고 겔이 염의 과립을 함유하는 겔.
  13. 버퍼를 함유하는 제1항의 겔.
  14. 제13항에 있어서, 버퍼가 시트르산나트륨, 인산칼륨 또는 이들의 혼합물인 겔.
  15. 방부제를 함유하는 제1항의 겔.
  16. 제15항에 있어서, 방부제가 메틸파라벤인 겔.
  17. 상처 치유약을 함유하는 제1항의 겔.
  18. 생장 인자를 함유하는 제17항의 겔.
  19. 제1항의 겔을 상처에 적용하는 것으로 되는 상처 치료방법.
  20. 제19항에 있어서, 가피를 함유한 상처에 제1항의 겔을 적용하고 겔이 그 위치에 잔류하여 가피를 유연하게 한다음 가피를 제거함으로써 괴사조직이 제거되는 처리방법.
  21. 제19항에 있어서, 겔을 드레싱 수단에 의해 적용되는 처리방법.
  22. 제8항 내지 제12항, 제17항 또는 제18항의 어느 하나에 의한 겔을 상처에 적용해서 되는 상처 처리 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910700602A 1989-10-27 1990-10-12 상처용 겔 조성물 및 이것의 사용방법 KR920700705A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/428,156 US5271943A (en) 1989-10-27 1989-10-27 Wound gel compositions containing sodium chloride and method of using them
US428156 1989-10-27
PCT/US1990/005681 WO1991006323A1 (en) 1989-10-27 1990-10-12 Wound gel compositions and methods of using them

Publications (1)

Publication Number Publication Date
KR920700705A true KR920700705A (ko) 1992-08-10

Family

ID=23697769

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910700602A KR920700705A (ko) 1989-10-27 1990-10-12 상처용 겔 조성물 및 이것의 사용방법

Country Status (13)

Country Link
US (1) US5271943A (ko)
EP (1) EP0452470B1 (ko)
JP (1) JP2617260B2 (ko)
KR (1) KR920700705A (ko)
AT (1) ATE163863T1 (ko)
AU (1) AU636686B2 (ko)
CA (1) CA2042609C (ko)
DE (1) DE69032125T2 (ko)
DK (1) DK124091A (ko)
IE (1) IE903638A1 (ko)
MY (1) MY107267A (ko)
PT (1) PT95695A (ko)
WO (1) WO1991006323A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050086324A (ko) * 2004-02-25 2005-08-30 김아란 3%부터 9%까지 셀라인 (염수)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2261671B (en) * 1991-11-16 1996-07-03 Gb Biotech Gel production from plant matter
WO1993010157A1 (en) * 1991-11-16 1993-05-27 Cpc International Inc. Cereal extracts
US5786470A (en) * 1991-11-16 1998-07-28 Dalgety Food Ingredients Limited Gel production from plant matter
US6033712A (en) 1994-05-13 2000-03-07 Ei Du Pont De Nemours And Company Gel production from plant matter
US7060287B1 (en) * 1992-02-11 2006-06-13 Bioform Inc. Tissue augmentation material and method
US7968110B2 (en) * 1992-02-11 2011-06-28 Merz Aesthetics, Inc. Tissue augmentation material and method
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5670169A (en) * 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
US5503825A (en) * 1994-01-10 1996-04-02 Lane; Barry Lip balm composition
US5762955A (en) * 1994-02-04 1998-06-09 Smith; Stephen Jay Method for application and maintenance of medication on body tissue
US6780425B1 (en) * 1994-02-04 2004-08-24 Stephen J. Smith Method for application and maintenance of medication on body tissue
US5399359A (en) * 1994-03-04 1995-03-21 Edward Mendell Co., Inc. Controlled release oxybutynin formulations
AU687840B2 (en) * 1994-03-15 1998-03-05 Dorothy E. Stofer Topical composition for burn relief and method of use
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form
US5814031A (en) * 1995-03-02 1998-09-29 Mooney; Mark Structured occllusive dressings
US5654013A (en) 1995-03-13 1997-08-05 Taylor; Lesli A. Method for treating rosacea
WO1997003710A1 (en) * 1995-07-19 1997-02-06 Innovative Technologies Limited Wound treatment composition
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
WO1997026865A1 (en) * 1996-01-29 1997-07-31 Edward Mendell Co., Inc. Sustained release excipient
US6309661B1 (en) 1996-02-28 2001-10-30 Carla A. Haynes Solid polysaccharide materials for use as wound dressings
US5587156A (en) * 1996-04-18 1996-12-24 Critical Dimension, Incorporated Shaving compositions containing particulate additives
US6800278B1 (en) 1996-10-28 2004-10-05 Ballard Medical Products, Inc. Inherently antimicrobial quaternary amine hydrogel wound dressings
US5849281A (en) * 1996-11-12 1998-12-15 S. C. Johnson & Son, Inc. Method of soap-free shaving
ATE363292T1 (de) * 1998-09-04 2007-06-15 Scios Inc Hydrogelzusammensetzungen mit kontrollierter freigabe von wachstumsfaktoren
US6469066B1 (en) * 1998-12-18 2002-10-22 Palladin Healthcare International, Ltd. Composition for pain mediation and apparatus and method of use thereof
US6333054B1 (en) 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
JP2001139477A (ja) * 1999-11-17 2001-05-22 Coherent Technology:Kk 創傷部位の組織細胞増殖促進液
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
US6548727B1 (en) 2000-02-17 2003-04-15 3M Innovative Properties Company Foam/film composite medical articles
US6977323B1 (en) 2000-02-17 2005-12-20 3M Innovative Properties Company Foam-on-film medical articles
US20060122082A1 (en) * 2000-02-17 2006-06-08 Leonard Paul Foam/spray producing compositions and dispensing system therefor
US20030104386A1 (en) * 2001-08-31 2003-06-05 The Regents Of The University Of California Methods for the specific detection of redox-active tags and the use thereof for capillary gel electrophoresis and DNA sequencing
JP5140218B2 (ja) 2001-09-14 2013-02-06 有限会社コヒーレントテクノロジー 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法
ATE535262T1 (de) 2001-12-05 2011-12-15 Oculus Innovative Sciences Inc Verfahren und vorrichtung zur erzeugung von wasser mit negativem und positivem redoxpotential (orp)
WO2003086353A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
PT1358883E (pt) * 2002-04-30 2007-10-01 Sifi Spa Composições farmacêuticas de re-epitelização contendo goma xantana
CA2495541C (en) * 2002-09-11 2011-07-12 Johnson & Johnson Medical Limited Wound dressing materials comprising complexes of anionic polysaccharides with silver
WO2004024187A2 (en) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
US7236820B2 (en) * 2003-01-29 2007-06-26 Sandhill Scientific, Inc. Standardized swallow challenge medium and method of use for esophageal function testing
IL156374A0 (en) * 2003-06-10 2004-01-04 Danenberg Holdings 2000 Ltd N Method for removing a pigmented section of skin
IL157696A0 (en) * 2003-09-01 2004-03-28 Hawk Medical Technologies Ltd Apparatus and method for removing a pigmented section of skin
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
KR20070117589A (ko) 2005-02-15 2007-12-12 버지니아 커먼웰스 유니버시티 급성 지혈 및 급성 상처와 만성 궤양의 치료를 위한 광물기술
KR101532778B1 (ko) 2005-03-23 2015-06-30 오클루스 이노바티브 사이언시즈 인코포레이티드 산화 환원 전위 수용액을 사용한 2도 및 3도 화상의 치료방법
KR20080011312A (ko) 2005-05-02 2008-02-01 오클루스 이노바티브 사이언시즈 인코포레이티드 치과용 용도에서 산화 환원 전위 수용액의 사용 방법
BRPI0614477A2 (pt) * 2005-08-01 2011-03-29 Hawk Medical Technologies Ltd uso de ácido salicìlico para a erradicação de pigmentação em uma área de pele, aparelho para essa erradicação e método de utilização de um aparelho para perfuração da pele
US20070048249A1 (en) 2005-08-24 2007-03-01 Purdue Research Foundation Hydrophilized bactericidal polymers
WO2007056066A2 (en) 2005-11-04 2007-05-18 Lifescience Plus, Inc. Bioabsorbable hemostatic gauze
JP2009523832A (ja) 2006-01-20 2009-06-25 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を用いた腹膜炎の治療又は予防方法
US20070184087A1 (en) * 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US9463119B2 (en) * 2007-01-18 2016-10-11 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
PT103765A (pt) * 2007-06-20 2008-12-22 Inst Superior Tecnico Síntese e aplicação de uma família de novos materiais resultantes do cruzamento entre gelatina e sais orgânicos
CA2730009C (en) * 2007-07-12 2017-08-15 Whipbird Pain Relief Pty Ltd. Topical medicament
FR2921071A1 (fr) * 2007-09-14 2009-03-20 Jean Francois Regis Moreel Procede de prelevement et de detection et/ou d'identification de microorganismes presents dans un echantillon
WO2010124280A2 (en) * 2009-04-24 2010-10-28 New Century Pharmaceuticals, Inc. Human serum albumin-based topical ointment for treatment of acne, psoriasis, egfr-induced toxicity, premature skin aging and other skin conditions
MX348304B (es) 2009-06-15 2017-06-02 Invekra S A P I De C V Solucion que contiene acido hipocloroso y metodos para usar la misma.
US9119605B2 (en) 2010-05-06 2015-09-01 Zimmer, Inc. Synthetic polymer adhesives and methods for making, using and delivering the same
CN103170004B (zh) * 2012-04-23 2016-08-31 佛山市优特医疗科技有限公司 一种制备含银纤维伤口敷料的方法
US20210052767A1 (en) * 2012-04-23 2021-02-25 Foshan United Medical Technologies Ltd. Antimicrobial fiber comprising silver, fabric and wound dressing comprising the antimicrobial fiber, and methods for manufacturing the fiber, the fabric, and the wound dressing
KR102037150B1 (ko) 2012-06-22 2019-10-28 지-메디카 엘엘씨 지혈 장치
WO2015075406A1 (en) 2013-11-19 2015-05-28 Lipopeptide Ab New treatment of chronic ulcers
AU2017211721B2 (en) 2016-01-31 2022-01-13 Mediwound Ltd. Debriding composition for treating wounds
ES2936404T3 (es) 2016-04-18 2023-03-16 Mediwound Ltd Formulaciones para el desbridamiento de heridas crónicas
JP2020513909A (ja) * 2016-12-22 2020-05-21 アプライド ティシュ テクノロジーズ エルエルシーＡｐｐｌｉｅｄ Ｔｉｓｓｕｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ 創傷治療のためのデバイスおよび方法
WO2018222622A1 (en) 2017-05-27 2018-12-06 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
EP3638740A1 (en) 2017-06-16 2020-04-22 Poly Group LLC Polymeric antimicrobial surfactant
US11141458B2 (en) * 2019-07-17 2021-10-12 Mycomagic Biotechnology Co., Ltd. Composition and methods for promoting and treating chronic wound healing
US20210186873A1 (en) * 2019-12-19 2021-06-24 Zaki Yusuf Gel compositions for mitigation of burn injuries, kits containing the gel compositions, and associated methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192727A (en) * 1976-08-24 1980-03-11 Union Carbide Corporation Polyelectrolyte hydrogels and methods of their preparation
US4125478A (en) * 1976-11-26 1978-11-14 The Dow Chemical Company Air treating gel employing amide polymer gelling agent
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
US4369124A (en) * 1979-09-14 1983-01-18 Halliburton Company High viscosity complexed aqueous gels and methods and additives for forming such gels
US4318746A (en) * 1980-01-08 1982-03-09 Ipco Corporation Highly stable gel, its use and manufacture
US4393048A (en) 1980-02-15 1983-07-12 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for wounds
US4299825A (en) * 1980-07-03 1981-11-10 Celanese Corporation Concentrated xanthan gum solutions
GB2108517B (en) 1981-06-12 1985-06-12 Nat Res Dev Hydrogels
JPS58206751A (ja) 1982-05-26 1983-12-02 日石三菱株式会社 創傷被覆材
US4604384A (en) 1982-06-24 1986-08-05 Smith Robert A Pharmaceutical gel composition
US4540568A (en) * 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
US4732755A (en) 1983-01-17 1988-03-22 University Of Health Sciences/The Chicago Medical School Skin burn treatment
AU4198785A (en) * 1984-05-07 1985-11-14 Lloyd A. Ferreira Conductive material and biomedical electrode
US4671267A (en) 1984-05-30 1987-06-09 Edward I. Stout Gel-based therapy member and method
US4587284A (en) 1985-06-14 1986-05-06 Ed. Geistlich Sohne Ag Fur Chemische Industrie Absorbent polymer material and its preparation
US4692328A (en) * 1985-09-24 1987-09-08 Dynatech Corporation Biologically useful polymer preparations
US4800815A (en) * 1987-03-05 1989-01-31 Halliburton Company Shaped charge carrier
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
FR2620866B1 (fr) * 1987-09-18 1989-12-01 Rhone Poulenc Chimie Procede de preparation de materiaux supraconducteurs et materiaux ainsi obtenus
US4944948A (en) * 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050086324A (ko) * 2004-02-25 2005-08-30 김아란 3%부터 9%까지 셀라인 (염수)

Also Published As

Publication number Publication date
DE69032125D1 (de) 1998-04-16
AU636686B2 (en) 1993-05-06
MY107267A (en) 1995-10-31
US5271943A (en) 1993-12-21
EP0452470A1 (en) 1991-10-23
AU6743490A (en) 1991-05-31
DE69032125T2 (de) 1998-07-02
JPH04502569A (ja) 1992-05-14
CA2042609C (en) 2001-10-02
PT95695A (pt) 1991-09-13
ATE163863T1 (de) 1998-03-15
CA2042609A1 (en) 1991-04-28
IE903638A1 (en) 1991-05-08
WO1991006323A1 (en) 1991-05-16
EP0452470B1 (en) 1998-03-11
DK124091A (da) 1991-08-20
JP2617260B2 (ja) 1997-06-04
DK124091D0 (da) 1991-06-25

Similar Documents

Publication Publication Date Title
KR920700705A (ko) 상처용 겔 조성물 및 이것의 사용방법
NO992980D0 (no) Nitroimidazol gelblanding
DE59209658D1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
DK0507878T3 (da) Komposit af en dispergeret gel i en klæbestofmatrix og fremgangsmåde til fremstilling deraf
ATE205723T1 (de) Applikation von sod in liposomen
ATE103487T1 (de) Betaeubungs- und feuchtigkeitszusammensetzung und verfahren zur herstellung.
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
BR0008787A (pt) Sistema à base de colágeno injetável para aplicação de células ou agentes terapêuticos
DE69322809D1 (de) Biopolymerverbundmaterial
ROENIGK Jr Dermabrasion: state of the art
Rubin Trichloroacetic acid and other non-phenol peels
ES2153501T3 (es) Agente para el tratamiento del cabello.
CA1334649C (en) Chemical splinter removal
SCHUESSLER et al. Dermal grafts for correction of facial defects (a series of 80 cases)
DE69723725D1 (de) Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer
MILLER et al. HEALING OF SECOND DEGREE BURNS: Comparison of Effects of Early Application of Horaografts and Coverage with Tape
Stone et al. The effect of stannous fluoride and stannous chloride on inflammation
DE69329198T2 (de) Erneuerung von durch externe faktoren gealterter haut mittels transdermaler anwendung von selenoaminosäuren
DE69917756D1 (de) Methoden zur behandlung von neurombedingten schmerzen
Kaufman et al. Treatment of chronic leg ulcers with Op-Site
Deprez Easy peel for the treatment of stretch marks
Al-Khateeb et al. The management and repair of wounds of the face
Raghupathi Clinical study of Sterile Collagen Particles (BIOFIL) in the management of Chronic Non Healing Ulcer
RU94017134A (ru) Способ кожной пластики
FR2288515A1 (fr) Nouveau produit phytotherapeutique a action dermatologique

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application